FR2840203B1 - Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement - Google Patents

Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement

Info

Publication number
FR2840203B1
FR2840203B1 FR0206886A FR0206886A FR2840203B1 FR 2840203 B1 FR2840203 B1 FR 2840203B1 FR 0206886 A FR0206886 A FR 0206886A FR 0206886 A FR0206886 A FR 0206886A FR 2840203 B1 FR2840203 B1 FR 2840203B1
Authority
FR
France
Prior art keywords
treatment
pharmaceutical composition
soft capsules
oral pharmaceutical
capsules containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0206886A
Other languages
English (en)
Other versions
FR2840203A1 (fr
Inventor
Joel Bougaret
Elie Leverd
Marie Madeleine Bohn
Norbert Heintz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0206886A priority Critical patent/FR2840203B1/fr
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Priority to EP03731404A priority patent/EP1530459B1/fr
Priority to AU2003240808A priority patent/AU2003240808B2/en
Priority to MXPA04006054A priority patent/MXPA04006054A/es
Priority to JP2004508741A priority patent/JP4718170B2/ja
Priority to ES03731404T priority patent/ES2343790T3/es
Priority to PCT/US2003/016732 priority patent/WO2003101383A2/fr
Priority to PT03731404T priority patent/PT1530459E/pt
Priority to BRPI0307816A priority patent/BRPI0307816B8/pt
Priority to DK03731404.4T priority patent/DK1530459T3/da
Priority to DE60331920T priority patent/DE60331920D1/de
Priority to RU2004119829/15A priority patent/RU2279873C2/ru
Priority to AT03731404T priority patent/ATE462419T1/de
Priority to SI200331808T priority patent/SI1530459T1/sl
Priority to CNB038044390A priority patent/CN1287794C/zh
Publication of FR2840203A1 publication Critical patent/FR2840203A1/fr
Application granted granted Critical
Publication of FR2840203B1 publication Critical patent/FR2840203B1/fr
Priority to HK05110442.8A priority patent/HK1079421A1/xx
Priority to BRC10307816A priority patent/BRPI0307816F1/pt
Priority to CY20101100516T priority patent/CY1110184T1/el
Priority to JP2010221628A priority patent/JP5334937B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0206886A 2002-05-31 2002-05-31 Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement Expired - Lifetime FR2840203B1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR0206886A FR2840203B1 (fr) 2002-05-31 2002-05-31 Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement
MXPA04006054A MXPA04006054A (es) 2002-05-31 2003-05-28 Composicion farmaceutica oral para capsulas blandas que contienen vinorelbine y metodo de tratamiento.
RU2004119829/15A RU2279873C2 (ru) 2002-05-31 2003-05-28 Пероральная фармацевтическая композиция для мягких капсул, содержащая винорелбин, и способ лечения
JP2004508741A JP4718170B2 (ja) 2002-05-31 2003-05-28 ビノレルビンを含むソフトカプセルのための経口製薬組成物及び治療方法
ES03731404T ES2343790T3 (es) 2002-05-31 2003-05-28 Composicion farmaceutica oral para capsulas blandas que contienen vinorelbina y un metodo de tratamiento.
PCT/US2003/016732 WO2003101383A2 (fr) 2002-05-31 2003-05-28 Composition pharmaceutique orale pour capsules souples contenant de la vinorelbine et procede de traitement correspondant
PT03731404T PT1530459E (pt) 2002-05-31 2003-05-28 Composição farmacêutica oral para cápsulas moles contendo vinorelbina e método de tratamento
BRPI0307816A BRPI0307816B8 (pt) 2002-05-31 2003-05-28 composição farmacêutica oral líquida adequada como uma composição de carga líquida para uma forma de dosagem de cápsula macia
DK03731404.4T DK1530459T3 (da) 2002-05-31 2003-05-28 Oral farmaceutisk sammensætning til bløde kapsler indeholdende vinorelbin samt fremgangsmåde til behandling
SI200331808T SI1530459T1 (sl) 2002-05-31 2003-05-28 Oralni farmacevtski sestavek za mehke kapsule, ki vsebujejo vinorelbin in postopek obdelave
EP03731404A EP1530459B1 (fr) 2002-05-31 2003-05-28 Composition pharmaceutique orale pour capsules souples contenant de la vinorelbine et procede de traitement correspondant
AT03731404T ATE462419T1 (de) 2002-05-31 2003-05-28 Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
AU2003240808A AU2003240808B2 (en) 2002-05-31 2003-05-28 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
CNB038044390A CN1287794C (zh) 2002-05-31 2003-05-28 用于软胶囊的含有长春瑞滨的口服医药组合物及治疗方法
DE60331920T DE60331920D1 (de) 2002-05-31 2003-05-28 Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
HK05110442.8A HK1079421A1 (en) 2002-05-31 2005-11-18 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
BRC10307816A BRPI0307816F1 (pt) 2002-05-31 2006-05-26 Usos de uma composição de carga farmacêutica oral líquida para forma de dosagem de cápsula macia
CY20101100516T CY1110184T1 (el) 2002-05-31 2010-06-11 Φαρμακευτικη συνθεση για μαλακες καψουλες για χορηγηση απο το στομα η οποια περιεχει βινορελβινη και μεθοδος θεραπειας
JP2010221628A JP5334937B2 (ja) 2002-05-31 2010-09-30 ビノレルビンを含むソフトカプセルのための経口製薬組成物及び治療方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0206886A FR2840203B1 (fr) 2002-05-31 2002-05-31 Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement

Publications (2)

Publication Number Publication Date
FR2840203A1 FR2840203A1 (fr) 2003-12-05
FR2840203B1 true FR2840203B1 (fr) 2004-08-27

Family

ID=29558973

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0206886A Expired - Lifetime FR2840203B1 (fr) 2002-05-31 2002-05-31 Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement

Country Status (1)

Country Link
FR (1) FR2840203B1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
FR2623089B1 (fr) * 1987-11-13 1990-04-27 Pf Medicament Composition pharmaceutique pour l'administration parenterale de navelbine
GB9303719D0 (en) * 1993-02-24 1993-04-14 Wellcome Found Antiviral therapy
US6011041A (en) * 1995-07-28 2000-01-04 University Of British Columbia Use of anhydrovinblastine
JP2002541088A (ja) * 1999-04-01 2002-12-03 イネックス ファーマシューティカルズ コーポレイション リンパ腫の治療のための組成物および方法

Also Published As

Publication number Publication date
FR2840203A1 (fr) 2003-12-05

Similar Documents

Publication Publication Date Title
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
MA26622A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
IL238491A0 (en) Oral pharmaceutical preparation for soft capsules containing vinorelbine and methods of treatment
IL166108A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
MA26654A1 (fr) Pyrrolopyrimidines nouvelles procede pour leur preparation et compositions pharmaceutiques les contenant
PL357856A1 (en) Pharmaceutical granules containing tamsulozine and method of their manufacture
CY2007033I1 (el) Μεθοδος και φαρμακευτικο σκευασμα για την αντιμετωπιση της αντιστασης στα αντιυπερτασικα φαρμακα και για σχετικες παθησεις
GEP20053720B (en) Triamide-Substituted Indoles, Benzofuranes and Benzothiophenes as Inhibitors of Microsomal Triglyceride Transfer Protein (MTP) and/or Apolipoprotein B (Apo B) Secretion
DE60118571D1 (de) Pharmazeutische zusammensetzungen zur behandlung von krebs welche thalidomid und topoisomerase inhibitoren enthalten
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
HUP0304045A3 (en) Use of ikb-kinase inhibitors for treating of inflammatory and immune diseases and pharmaceutical compositions containing them
ATE522218T1 (de) Dosierungseinheit enthaltend prostaglandin-analog zur behandlung von darmverstopfung
IL166054A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
PT1441769E (pt) Formulacoes farmaceuticas contendo baixa concentracao de peroxido para tratamento ou prevencao de infeccoes vaginais
MA26899A1 (fr) PREPARATIONS CONTENANT UN MEDICAMENT GLUCOCORTICOiDE POUR LE TRAITEMENT DES MALADIES BRONCHOPULMONAIRES.
DE60127552D1 (de) Intrakorporelle medikamente zur hoch-energetischen phototherapeutischen behandlung von krankheiten
FR2840203B1 (fr) Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement
ATE400277T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
FR2863891B1 (fr) Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
DZ3225A1 (fr) Methode et compositions pour le traitement des maladies pulmonaires
FR2834643B1 (fr) Composition pharmaceutique anti-depressive contenant un extrait de polygala et son procede de preparation
DE60203878D1 (de) Verfahren zur vorbeugung gegen und behandlung von unterleibsschmerzen und magen-darmerkrankungen
FR2821080B1 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques
MA26639A1 (fr) 3-cetoderives tricycliques de 6-0-methylerythromycine, procede pour leur preparation et compositions pharmaceutiques les contenant
HUP0303029A3 (en) Use of pharmaceutical compositions containing cgmp-5pde inhibitors for treatment of wounds

Legal Events

Date Code Title Description
AU Other action affecting the ownership or exploitation of an industrial property right

Effective date: 20150212

CA Change of address

Effective date: 20150212

CD Change of name or company name

Owner name: CATALENT PHARMA SOLUTIONS, INC, US

Effective date: 20150212

CJ Change in legal form

Effective date: 20150212

CL Concession to grant licences

Name of requester: R.P. SCHERER CORPORATION, US

Effective date: 20150212

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20